アディポネクチンと冠動脈疾患:前向きな研究とメタ解析
Naveed Sattar1, Goya Wannamethee, Nadeem Sarwar
1University Department of Vascular Biochemistry, Glasgow, Scotland. nsattar@clinmed.gla.ac.uk
Circulation
|August 9, 2006
まとめ
アディポネクチンのレベルは,冠動脈疾患 (CHD) のリスクと弱い関連を示しています. この前向きな研究とメタアナリシスでは,アディポネクチンと心臓病との間に有意な関連性が見つかりませんでしたが,2型糖尿病との強い関連性があります.
科学分野:
- 心血管科学 心血管科学
- メタボリック・ヘルス メタボリック・ヘルス
- バイオマーカーの研究
背景:
- アディポネクチンと冠動脈疾患 (CHD) のリスクとの関連は完全に理解されていません.
- 既存の研究は,心臓血管疾患におけるアディポネクチンの役割に関する矛盾する証拠を提示しています.
研究 の 目的:
- 循環中のアディポネクチン濃度と,心血管疾患を発症するリスクとの関連を調査する.
- メタアナリシスにおける既存の研究と新しい見通しデータを統合する.
主な方法:
- 5661人の男性 (40-59歳) の前向きなコホートの中で,ネストされた症例対照研究が行われました.
- ベースラインの血清アディポネクチンのレベルは,心血管疾患のイベントを患った589人の男性と1231人の対照群で測定されました.
- 現在の研究を含む7つの前向きな研究のメタ分析を行い,CHDリスクの推定をまとめました.
主要な成果:
- アディポネクチンのレベルは,HDLコレステロールと正に相関し,C反応性タンパク質とBMIと逆に相関した.
- CHD症例と対照群の間で,アディポネクチンの中央値の有意な差は見つかりませんでした.
- 1318件のCHD症例のメタ解析は,アディポネクチンレベルを超えてCHDの非有意な確率比0.84 (95%CI,0.70から1.01) を示した.
結論:
- アディポネクチン濃度と心血管疾患のリスクとの関連は,II型糖尿病との強い関連とは対照的に,適度なようです.
- 心血管疾患の病原性におけるアディポネクチンの正確な役割を明らかにするために,さらなる研究が必要である.
さらに関連する動画
関連する概念動画
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease III: Clinical Manifestations
632
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
632
Coronary Artery Disease IV: Preventive Measures
893
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
961
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
961
Acute Coronary Syndrome III: Diagnostic Studies
502
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502


